[DOI] [PMC free article] [PubMed] [Google Scholar] 123.Parker K.J., Oztan O., Libove R.A., Mohsin N., Karhson D.S., Sumiyoshi R.D., Summers J.E., Hinman K.E., Motonaga K.S., Phillips J.M., et al
In tendon fibroblasts, BPC-157 has been reported to increase expression of growth hormone receptor at mRNA and protein levels, potentially priming cells to respond to growth hormone via downstream Janus kinase (JAK) signaling
Half of the participants received the active treatment, while the other half received a placebo
Albiglutide (GlaxoSmithKline) is a fusion of two GLP-1 molecules with human albumin, which increases the proteolytic stability of GLP-1 and slows renal clearance, extending the half-life to 120 h
Note: doses as low as 1.2 g daily in humans might confer a pro-oxidant effect, lowering GSH and increasing the GSH/GSSG ratio